Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Low Dose Growth Hormone (GH) on Insulin Sensitivity and Cortisol Production Rates

This study has been completed.
Information provided by (Responsible Party):
Kevin Yuen, Oregon Health and Science University Identifier:
First received: August 15, 2007
Last updated: May 2, 2012
Last verified: May 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2012
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):